BCG immunotherapy of bladder cancer: 20 years on.
Alexandroff
A B
AB
Department of Surgery, Edinburgh University, UK.
Jackson
A M
AM
O'Donnell
M A
MA
James
K
K
D001500:BCG Vaccine / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007111:Immunity, Cellular; D016233:Immunotherapy, Active; D013601:T-Lymphocytes / Q000276:immunology; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine; D016207:Cytokines